Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 12 studies | 27% ± 7% | |
classical monocyte | 12 studies | 21% ± 8% | |
non-classical monocyte | 7 studies | 22% ± 9% | |
monocyte | 6 studies | 22% ± 4% | |
conventional dendritic cell | 6 studies | 22% ± 5% | |
myeloid cell | 6 studies | 28% ± 7% | |
mononuclear phagocyte | 5 studies | 22% ± 7% | |
dendritic cell | 4 studies | 35% ± 11% | |
neutrophil | 4 studies | 20% ± 5% | |
endothelial cell of vascular tree | 4 studies | 18% ± 3% | |
natural killer cell | 3 studies | 16% ± 1% | |
leukocyte | 3 studies | 20% ± 3% | |
naive B cell | 3 studies | 21% ± 5% | |
regulatory T cell | 3 studies | 18% ± 2% | |
endothelial cell | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 567.91 | 1445 / 1445 | 100% | 12.73 | 183 / 183 |
lung | 100% | 1345.03 | 578 / 578 | 100% | 11.11 | 1153 / 1155 |
breast | 100% | 759.80 | 459 / 459 | 99% | 11.44 | 1111 / 1118 |
bladder | 100% | 647.52 | 21 / 21 | 99% | 9.01 | 499 / 504 |
uterus | 100% | 592.42 | 170 / 170 | 98% | 9.54 | 452 / 459 |
thymus | 100% | 685.27 | 653 / 653 | 98% | 7.63 | 593 / 605 |
intestine | 100% | 597.54 | 966 / 966 | 98% | 9.36 | 516 / 527 |
stomach | 100% | 421.18 | 359 / 359 | 98% | 9.88 | 280 / 286 |
brain | 97% | 357.68 | 2574 / 2642 | 100% | 6.83 | 702 / 705 |
ovary | 100% | 504.92 | 180 / 180 | 97% | 5.29 | 416 / 430 |
kidney | 100% | 563.08 | 89 / 89 | 95% | 8.88 | 857 / 901 |
pancreas | 95% | 283.64 | 311 / 328 | 98% | 10.33 | 175 / 178 |
prostate | 100% | 600.91 | 245 / 245 | 93% | 4.29 | 466 / 502 |
skin | 100% | 493.96 | 1800 / 1809 | 90% | 7.42 | 427 / 472 |
adrenal gland | 100% | 390.05 | 257 / 258 | 78% | 3.08 | 180 / 230 |
liver | 96% | 254.63 | 217 / 226 | 60% | 2.50 | 243 / 406 |
adipose | 100% | 908.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.84 | 29 / 29 |
spleen | 100% | 1321.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.68 | 1 / 1 |
muscle | 99% | 408.62 | 794 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 436.14 | 1319 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1691.52 | 914 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 305.43 | 819 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 36% | 1.45 | 29 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF267 |
Protein name | Zinc finger protein 267 Zinc finger protein 267 (Zinc finger protein HZF2) |
Synonyms | |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | I3L4I6 ENST00000561814.1 H3BNA3 H3BMG2 H3BPW2 ENST00000394846.7 ENST00000300870.15 ENST00000566541.5 Q14586 ENST00000562971.1 |